When DNA and medical tests disagree about breast cancer risk, which to believe? : foxnews

as declared in foxnews

When DNA and medical tests disagree about breast cancer risk, which to believe?

When DNA and medical tests disagree about breast cancer risk, which to believe?

It's a dilemma more and more cancer patients will face as genetic testing becomes part of everyday health care: When a DNA test indicates low risk of a tumor spreading, but traditional tests show a high risk, which do you believe?According to a large European study of 6,693 patients published on Wednesday, many women with early breast cancer can safely believe the genetic test.Patients who skipped chemotherapy when a genetic test showed low risk of the cancer advancing but a traditional test suggested high risk were almost as likely to survive five years without the cancer recurring as those who had chemo.(The traditional tests look for cancer cells in lymph nodes and fast-dividing cells, for instance, and include demographic facts of life, such as being over 50.)


in the same way indiatimes

16-yr-old PIO claims breast cancer cure

16-yr-old PIO claims breast cancer cure

Krtin NithiyanandamLondon: A 16-year-old Indian-origin boy from UK's Surrey has claimed to have found a treatment for the most deadly form of breast cancer.Krtin Nithiyanandam thinks he has devised a way to turn the triple negative breast cancer into a kind which responds to drugs.Around 7,500 women each year are diagnosed with triple negative breast cancer, a type of disease which does not respond to today's most effective drugs.Many breast cancers are driven by oestrogen, progesterone or growth chemicals, so drugs that can block those fuels, such as tamoxifen, make effective treatments.


additionally telegraph

16-year-old devises way to make deadly breast cancer more treatable

16-year-old devises way to make deadly breast cancer more treatable

A teenager believes he has solved the problem of how to make a deadly form of breast cancer more treatable.Around 7,500 women each year are diagnosed with triple negative breast cancer, a type of disease which does not respond to today's most effective drugs.Many breast cancers are driven by oestrogen, progesterone or growth chemicals so drugs that can block those fuels, such as tamoxifen, make effective treatments.However triple negative breast cancer does not have receptors and it can only be treated with a gruelling combination of surgery, radiation and chemotherapy which lowers the chance of survival.